Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MSLP on a "national stock exchange"
Added Bluher, "The board additions represent an important step in our corporate restructuring. The expansion is part of our positioning to qualify for and eventually list the company's securities on a national stock exchange."
"sorry for your loss"
He wont lose anything because todays .017 shares would now be worth $1.70
GLTY
"Our new board members will add depth and experience to MusclePharm, as the company enters an exciting new stage of growth and development," Pyatt said. "I extend special thanks to our co-founder Cory Gregory for his service and contributions to MusclePharm's board. We look forward to Cory's continued, valued role as president."
Added Bluher, "The board additions represent an important step in our corporate restructuring. The expansion is part of our positioning to qualify for and eventually list the company's securities on a national stock exchange."
Burr currently is chief executive officer of Video Gaming Services, Inc., Denver; Prosser is chief executive officer of Arete Industries, Inc., a publicly-traded company based in Westminster, CO, that holds oil and gas properties in the Rocky Mountain region; and Groussman is an investment professional and principal of Boca Raton-based Bull Hunter Inc.
On July 14, 2012, the Company appointed Mark Groussman to its Board of Directors. Mr. Groussman's appointment to the Board was pursuant to the terms of one of the Consulting Agreements reported in Item 1.01 above between the Company and Melechdavid, Inc. (the "Consultant"), a corporation owned by Mr. Groussman. Additional terms of the Consulting Agreement are described under Item 1.01 above.
Biographical Background: Mark Groussman, age 39, was appointed as the Chief Executive Officer of American Strategic Minerals Corporation in June 2012. Mr. Groussman has been a consultant and investor in both private and public companies for the past 11 years. Mr. Groussman has been the managing member of Bull Hunter LLC since 2001 and the president of Melechdavid, Inc. since 2001. Both of these companies invest in small capitalization in private and public companies. Mr. Groussman received his B.A. from George Washington University in 1995 and received a M.S. in Real Estate Finance from New York University in 1999.Mr. Groussman's appointment to the Board was pursuant to the terms of a consulting agreement between the Company and Melechdavid, Inc., a corporation owned by Mr. Groussman.
Thanks turokman
GLTY
"Informed Choice website has MP logo back up, and its products are back up"
It's ON
ON
GLTY
John Bluher, Chief Operating Officer of MusclePharm, said,
"These prompt and voluntary actions demonstrate our officers' commitment to the company. We will be seating a reconstituted board very soon and will seek in the near term to enter into new compensation agreements with all of our executive officers, subject to review and approval by independent board members. The new contracts are expected to align executive compensation at the company with growth of our margins and net income."
USP Labs ....Maybe they will fold?
Their main product has DMAA which is being banned in most countries now
"You worried it may be the one you work for and you haven't gotten the memo?..."
Maybe he works at USP Labs?
GLTY!
"You constantly mention other supplement companies on the brink of folding"
USP Labs is losing a major product
Maybe they will fold?
Finland follows Sweden and bans DMAA
All Nordic nations except Norway have joined the UK in acting against the pre-workout stimulant DMAA, with Sweden and Finland joining Denmark in issuing withdrawal alerts or destroying products.
Anna Mizrahi from the Finnish Food Safety Authority (Evira) told us the agency had taken action after viewing safety reports from its Danish and Swedish counterparts, coupled with a recently generated European Commission alert for one of the most popular DMAA-containing products – USP Labs’ Jack3D.
Finnish importers of Jack3D have been told to withdraw the product and some batches are being destroyed, Mizrahi said. Most of them are sold via online retailers.
Authorities in Denmark have already cleared the market of all DMAA (methylhexaneamine/1,3-dimethylamylamine) products while Sweden has taken action in Stockholm with other municipalities in the country set to follow.
“We have been in contact with Denmark and Sweden and may also contact other agencies,” said Mizrahi, although she acknowledged the agency was not in possession of any adverse event reports.
“…not appropriate for human consumption…”
The Danish report (published October 2011) and Swedish report (May 2012) highlighted heart and brain-related safety concerns conveyed in two studies about DMAA (Salinger 2011; Gee 2010), especially in conjunction with caffeine consumption.
“Risk assessment by the Danish and Swedish Food Safety Authorities has concluded that DMAA is not appropriate for human consumption due to its associated health risks,” Evira said.
“The American Food and Drug Administration in the USA has also issued a warning concerning dietary supplements containing DMAA and restricted its use.”
Evira said its market sweep would not stop at Jack3D. “Evira is aware that additional dietary supplements containing DMAA are available for sale in Finland under other brand names. This withdrawal will eventually be extended to these products as well.”
Just last week, Food Standards Australia New Zealand (FSANZ) issued a consumer safety warning of its own, with 11 products under investigation.
Those products are: Noxpump; 3-D explosion; Beta-Cret; PreSurge; 1 MR; Cyroshock,; Jack3D; Mesomorph; Neurocore; Oxyelite powder; Hemo Rage Black.
Italian-based EU food law expert Luca Bucchini, from Rome-based Hylobates Consulting, said information was being gathered that may provoke further European actions.
"It is probable that several adverse events have occurred in Europe as well, but have not been publicised yet,” he said.
For its part, USP Labs has sued retailers for making disparaging remarks about Jack3D and DMAA, and like most of the mainly US-based manufacturers that have been called into question, continues to defend the safety, efficacy and legitimate sourcing of the substance.
Ireland bans Jack3D: DMAA products are “illegal medicines”
?
http://www.nutraingredients.com/Regulation/Ireland-DMAA-products-are-illegal-medicines
Most OTC:BB and PINK SHEET penny stock companies use their stock as money to pay bonuses, salaries, debt and bills
Everybody should know that BEFORE buying them
Try looking at Lazard. (NYSE-LAZ) Last year they paid 62% of their net revenue in compensation to it's 2,500 staff at an average of $450,000 per employee
The stock is down almost 50%
This is just ONE example of many
"Don't forget about us"
"Please keep *YOUR* shareholders updated" would have sounded better
JMO
GLTY
I am starting to hear rumors that you are hearing rumors
LOL
GLTY
You really need to get your emotions in check dude
GLTY
Are you asking me what companies pay their directors with large bonuses that upset their shareholders?
Please rephrase your question as not to be so ill-tempered
"Now what is your take on th[img][/img]is cross listing."
I have not done enough reserch on it to form an opinion
I will look over the weekend if I have time
"The bonus did not show actions that are consistent with valuing shareholder value"
Most of the public traded companies dont
Dude, if you have a big problem with bonus structure of the head honchos of public traded companies then you should not be in the stock market. You should join the occupy wall street movement.
LOL
MSLP is NOT unique
Cross listing.....
Cross listing of one company on multiple exchanges should not be confused with dual listed companies, where two distinct companies - with separate stocks listed on different exchanges - function as one company.
Cross listing of shares is when a firm lists its equity shares on one or more foreign stock exchange in addition to its domestic exchange. Examples include: American Depository Receipt (ADR), European Depository Receipt (EDR), International Depository Receipt (IDR) and Global Registered Shares (GRS).
Generally such a company's primary listing is on a stock exchange in its country of incorporation, and its secondary listing(s) is on an exchange in another country. Cross-listing is especially common for companies that started out in a small market but grew into a larger market. For example, numerous large Canadian companies are listed on the New York Stock Exchange or NASDAQ as well as the Toronto Stock Exchange such as Enbridge and Research In Motion. Some organizations, such as Liberty Media, Comcast and Viacom, have multiple listings reflecting different voting rights.
What do managers say?
A questionnaire asking managers of international companies has shown that firms cross-list in the US mainly because of specific US business reasons (for instance US acquisitions, US business expansion and publicity), liquidity and status of US capital markets, and industry specific reasons (listing of competitors, benefits of financial analysts). Meeting SEC disclosure requirements and preparing US-GAAP reconciliations were cited as the most important disadvantages. Officials of ADR companies without an official listing (Level I and Rule 144A ADR’s) perceived the expansion of the US shareholder base as the principal benefit followed by specific US business reasons. On the question of what deters them from an official US listing, they mentioned the time-consuming and expensive US-GAAP reconciliations as well as listing fees as the hardest impediments. Additional disclosure requirements were cited as less difficult to overcome.
Do cross-listings create value?
There is a vast academic literature on the impact of cross-listings on the value of the cross-listed firms. Most studies (for example, Miller, 1999[4]) find that a cross-listing on a US stock market by a non-US firm is associated with a significantly positive stock price reaction in the home market. This finding suggests that the stock market expects the cross-listing to have a positive impact on firm value. Doidge, Karolyi, and Stulz (2004)[5] show that companies with a cross-listing in the U.S. have a higher valuation than non-cross-listed corporations, especially for firms with high growth opportunities domiciled in countries with relatively weak investor protection. The premium they find is larger for companies listed at official US stock exchanges (Level II and III ADR programs) than for over-the-counter listings (Level I ADR program) and private placements (Rule 144A ADR’s). Doidge, Karolyi, and Stulz (2004) argue that a cross-listing in the US reduces the extent to which controlling shareholders can engage in expropriation (through "bonding" to the high corporate governance standards in the US) and thereby increases the firm’s ability to take advantage of growth opportunities. Recent research, see www.crosslisting.com[1], shows that the listing premium for crosslisting has evaporated, due to new US regulations and competition from other exchanges. Some recent academic research finds that smaller foreign firms seeking cross listing venues may be opting for UK exchanges over US exchanges due to the costs imposed by the Sarbanes-Oxley Act. On the other hand, larger firms seeking "bonding" benefits from a US listing continue to seek a US exchange listing.[6] The academic literature largely ignores cross-listings on non-US exchanges. However, there are many cross-listings on exchanges in Europe and Asia. Even US firms are cross-listed in other countries. In the 1980s there was a wave of cross-listings of US firms in Japan. Roosenboom and van Dijk (2009)[7] analyze 526 cross-listings from 44 different countries on 8 major stock exchanges and document significant stock price reactions of 1.3% on average for cross-listings on US exchanges, 1.1% on London Stock Exchange, 0.6% on exchanges in continental Europe, and 0.5% on Tokyo Stock Exchange. These findings suggest that cross-listings on Anglo-Saxon exchanges create more value than on other exchanges. They also highlight the incomplete understanding of why firms cross-list outside the UK and the US, as many of the arguments discussed above (enhanced liquidity, improved disclosure, and bonding) do not apply.
http://en.wikipedia.org/wiki/Cross_listing
So this is just all just speculation on your part
You have no proof of your claims, right? So planting the 'seed' of 'shady' dealing in shareholders minds dont seem disingenuous to you?
I would bet a protein bar cost a lot more to produce because of the grains, fruit and fillers. It's more of a food and maybe they would have to deal and the FDA.
Just a guess
A meal replacement is good but EAS Myoplex and Met-RX would be hard to compete against
JMO
GLTY
"I want them to make me whole "
So dont the shareholders at RIMM, NOK, F, BAC, NFLX, ALU, RAD, WAG, BCS and 100's and 100's of other stocks how have had massive losses
Lets sue them all
GLTY
"I can definitely see them using both of these exchanges in the manner described in my last post"
Who exactly are "them"?
TIA
GLTY
"How much would you value this company at?"
I have no way of knowing what the intrinsic value of Muscle Pharm Corporation is but I would assume that it is a lot higher than the current stock price
JMO
of course
GLTY
"Holy cow! Fast are you saying that providing themselves 1/3 of as a stock bonus was deserved?"
Let's try again
dakotaben said "most of the dilution was from giving themselves undeserved bonuses"
I said "That's a matter of 'opinion'"
What's a matter of opinion is that they did not deserve bonuses and that "most" of the dilution came from bonuses
Now if you want to debate whether or not the bonuses were excessive or not that is a different topic
GLTY
"Once again... most of the dilution was from giving themselves undeserved bonuses"
That's a matter of 'opinion'
That's fine at least he gets the point that HIS shareholders are getting restless for some follow up news.
"there you go being rude again..."
The "LOL" means it was a joke
dont be so thin skinned
"so al mature, respectful question should be addressed..'
If it does not flag the SEC I agree
I am sure he gets more moronic questions like
"Would you consider your stock as a pump and dump stock?" than he does respectful but hard questions
It's very common for a penny stock startup company to dilute their shares by paying bills with stock
I would have NEVER paid $1 for this stock
That's insane
That's fine
Unfortunately the lack of news from the company has some of his shareholders resort to asking questions on his twitter.
GLTY
"They are too busy answering the cheerleaders on Twitter"
Do you mean the "cheerleaders on Twitter" who spend their money to buy the products and drive sales?
To many posters here are full of speculation
News will come, earnings will come
"Just asked him that on Twitter (I have no shame lol).
We'll see what he says"
I see no problem in asking hard questions as long as it's done in a mature and respectful manner
Thanks, let us know what he says if anything
GLTY
"It's almost like this is the MS LP executive board."
You mean the same executives that have launched one of the best selling line of supplements sold in over 120 countries and available in over 10,000 U.S. retail outlets and who have signed some of the most Elit athletes in the world who acually use their products?
Ya man, posters on this board is just like them
LOL
GLTY
LOL...
GLTY
"does this mean you'll be ready to slap it this afternoon?"
You really need to get a girlfriend dude
LOL
GLTY